The latest closing stock price for Viracta Therapeutics as of February 28, 2025 is 0.02.
An investor who bought $1,000 worth of Viracta Therapeutics stock at the IPO in 2005 would have $-1,000 today, roughly -1 times their original investment - a -38.50% compound annual growth rate over 19 years.
The all-time high Viracta Therapeutics stock closing price was 264.20 on March 29, 2006.
The Viracta Therapeutics 52-week high stock price is 1.31, which is 6450% above the current share price.
The Viracta Therapeutics 52-week low stock price is 0.01, which is 50% below the current share price.
The average Viracta Therapeutics stock price for the last 52 weeks is 0.42.
An investor who bought $1,000 worth of Viracta Therapeutics stock at the IPO in 2005 would have $-1,000 today, roughly -1 times their original investment - a -38.50% compound annual growth rate over 19 years.
The all-time high Viracta Therapeutics stock closing price was 264.20 on March 29, 2006.
The Viracta Therapeutics 52-week high stock price is 1.31, which is 6450% above the current share price.
The Viracta Therapeutics 52-week low stock price is 0.01, which is 50% below the current share price.
The average Viracta Therapeutics stock price for the last 52 weeks is 0.42.